Scopolamine reversal of nicotine enhanced delayed matching-to-sample performance in monkeys

Alvin V Terry, Jerry J. Buccafusco, William J. Jackson

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

The basis for the memory enhancing action of nicotine was evaluated in five adult monkeys (Macaca fascicularis) well trained in the performance of a delayed matching-to-sample (DTMS) paradigm. Nicotine (1.25-20 μg/kg, IM) produced a dose-dependent improvement in performance of the task. The optimal dose of nicotine for each monkey also improved performance when the animals were tested 24 h later in the no-drug situation. In the same animals, low doses of scopolamine produced a dose-dependent decrement in DTMS performance. A subthreshold dose (defined by DMTS performance decrement) of scopolamine was administered 20 min prior to the optimal dose of nicotine. Scopolamine pretreatment completely blocked the enhanced performance observed earlier with nicotine. The results of this study are consistent with the hypothesis that the enhanced cognitive performance associated with nicotine is due to central acetylcholine release and subsequent muscarinic receptor stimulation.

Original languageEnglish (US)
Pages (from-to)925-929
Number of pages5
JournalPharmacology, Biochemistry and Behavior
Volume45
Issue number4
DOIs
StatePublished - Jan 1 1993

Fingerprint

Scopolamine Hydrobromide
Nicotine
Haplorhini
Animals
Macaca fascicularis
Task Performance and Analysis
Muscarinic Receptors
Acetylcholine
Data storage equipment
Pharmaceutical Preparations

Keywords

  • Alzheimer's disease
  • Learning and memory
  • Matching-to-sample Cholinergic
  • Monkey
  • Nicotine
  • Scopolamine

ASJC Scopus subject areas

  • Biochemistry
  • Toxicology
  • Pharmacology
  • Clinical Biochemistry
  • Biological Psychiatry
  • Behavioral Neuroscience

Cite this

Scopolamine reversal of nicotine enhanced delayed matching-to-sample performance in monkeys. / Terry, Alvin V; Buccafusco, Jerry J.; Jackson, William J.

In: Pharmacology, Biochemistry and Behavior, Vol. 45, No. 4, 01.01.1993, p. 925-929.

Research output: Contribution to journalArticle

@article{22f22651d6f047739af8ae0e00aa9a46,
title = "Scopolamine reversal of nicotine enhanced delayed matching-to-sample performance in monkeys",
abstract = "The basis for the memory enhancing action of nicotine was evaluated in five adult monkeys (Macaca fascicularis) well trained in the performance of a delayed matching-to-sample (DTMS) paradigm. Nicotine (1.25-20 μg/kg, IM) produced a dose-dependent improvement in performance of the task. The optimal dose of nicotine for each monkey also improved performance when the animals were tested 24 h later in the no-drug situation. In the same animals, low doses of scopolamine produced a dose-dependent decrement in DTMS performance. A subthreshold dose (defined by DMTS performance decrement) of scopolamine was administered 20 min prior to the optimal dose of nicotine. Scopolamine pretreatment completely blocked the enhanced performance observed earlier with nicotine. The results of this study are consistent with the hypothesis that the enhanced cognitive performance associated with nicotine is due to central acetylcholine release and subsequent muscarinic receptor stimulation.",
keywords = "Alzheimer's disease, Learning and memory, Matching-to-sample Cholinergic, Monkey, Nicotine, Scopolamine",
author = "Terry, {Alvin V} and Buccafusco, {Jerry J.} and Jackson, {William J.}",
year = "1993",
month = "1",
day = "1",
doi = "10.1016/0091-3057(93)90141-F",
language = "English (US)",
volume = "45",
pages = "925--929",
journal = "Pharmacology Biochemistry and Behavior",
issn = "0091-3057",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Scopolamine reversal of nicotine enhanced delayed matching-to-sample performance in monkeys

AU - Terry, Alvin V

AU - Buccafusco, Jerry J.

AU - Jackson, William J.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - The basis for the memory enhancing action of nicotine was evaluated in five adult monkeys (Macaca fascicularis) well trained in the performance of a delayed matching-to-sample (DTMS) paradigm. Nicotine (1.25-20 μg/kg, IM) produced a dose-dependent improvement in performance of the task. The optimal dose of nicotine for each monkey also improved performance when the animals were tested 24 h later in the no-drug situation. In the same animals, low doses of scopolamine produced a dose-dependent decrement in DTMS performance. A subthreshold dose (defined by DMTS performance decrement) of scopolamine was administered 20 min prior to the optimal dose of nicotine. Scopolamine pretreatment completely blocked the enhanced performance observed earlier with nicotine. The results of this study are consistent with the hypothesis that the enhanced cognitive performance associated with nicotine is due to central acetylcholine release and subsequent muscarinic receptor stimulation.

AB - The basis for the memory enhancing action of nicotine was evaluated in five adult monkeys (Macaca fascicularis) well trained in the performance of a delayed matching-to-sample (DTMS) paradigm. Nicotine (1.25-20 μg/kg, IM) produced a dose-dependent improvement in performance of the task. The optimal dose of nicotine for each monkey also improved performance when the animals were tested 24 h later in the no-drug situation. In the same animals, low doses of scopolamine produced a dose-dependent decrement in DTMS performance. A subthreshold dose (defined by DMTS performance decrement) of scopolamine was administered 20 min prior to the optimal dose of nicotine. Scopolamine pretreatment completely blocked the enhanced performance observed earlier with nicotine. The results of this study are consistent with the hypothesis that the enhanced cognitive performance associated with nicotine is due to central acetylcholine release and subsequent muscarinic receptor stimulation.

KW - Alzheimer's disease

KW - Learning and memory

KW - Matching-to-sample Cholinergic

KW - Monkey

KW - Nicotine

KW - Scopolamine

UR - http://www.scopus.com/inward/record.url?scp=0027291370&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027291370&partnerID=8YFLogxK

U2 - 10.1016/0091-3057(93)90141-F

DO - 10.1016/0091-3057(93)90141-F

M3 - Article

VL - 45

SP - 925

EP - 929

JO - Pharmacology Biochemistry and Behavior

JF - Pharmacology Biochemistry and Behavior

SN - 0091-3057

IS - 4

ER -